- Home
- SNCR vs VSTM Comparison
SNCR vs VSTM Comparison
Compare SNCR & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- VSTM
- Stock Information
- Founded
- SNCR 2000
- VSTM 2010
- Country
- SNCR United States
- VSTM United States
- Employees
- SNCR N/A
- VSTM N/A
- Industry
- SNCR EDP Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- SNCR Technology
- VSTM Health Care
- Exchange
- SNCR Nasdaq
- VSTM Nasdaq
- Market Cap
- SNCR 137.5M
- VSTM 132.0M
- IPO Year
- SNCR 2006
- VSTM 2012
- Fundamental
- Price
- SNCR $11.25
- VSTM $3.88
- Analyst Decision
- SNCR
- VSTM Strong Buy
- Analyst Count
- SNCR 0
- VSTM 8
- Target Price
- SNCR N/A
- VSTM $14.57
- AVG Volume (30 Days)
- SNCR 81.2K
- VSTM 1.1M
- Earning Date
- SNCR 11-12-2024
- VSTM 11-06-2024
- Dividend Yield
- SNCR N/A
- VSTM N/A
- EPS Growth
- SNCR N/A
- VSTM N/A
- EPS
- SNCR N/A
- VSTM N/A
- Revenue
- SNCR $167,615,000.00
- VSTM $10,000,000.00
- Revenue This Year
- SNCR $7.76
- VSTM N/A
- Revenue Next Year
- SNCR $5.83
- VSTM $125.69
- P/E Ratio
- SNCR N/A
- VSTM N/A
- Revenue Growth
- SNCR 33.39
- VSTM N/A
- 52 Week Low
- SNCR $2.70
- VSTM $2.10
- 52 Week High
- SNCR $15.46
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- SNCR 43.11
- VSTM 63.77
- Support Level
- SNCR $10.45
- VSTM $3.11
- Resistance Level
- SNCR $11.44
- VSTM $3.76
- Average True Range (ATR)
- SNCR 0.57
- VSTM 0.33
- MACD
- SNCR -0.06
- VSTM 0.04
- Stochastic Oscillator
- SNCR 31.58
- VSTM 94.26
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.